Idg-accel China Growth Fund Iii L.p. - Net Worth and Insider Trading
Idg-accel China Growth Fund Iii L.p. Net Worth
The estimated net worth of Idg-accel China Growth Fund Iii L.p. is at least $6 Million dollars as of 2024-09-20. Idg-accel China Growth Fund Iii L.p. is the 10% Owner of CASI Pharmaceuticals Inc and owns about 977,337 shares of CASI Pharmaceuticals Inc (CASI) stock worth over $6 Million. Details can be seen in Idg-accel China Growth Fund Iii L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Idg-accel China Growth Fund Iii L.p. has not made any transactions after 2018-03-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Idg-accel China Growth Fund Iii L.p.
Idg-accel China Growth Fund Iii L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Idg-accel China Growth Fund Iii L.p. owns 1 companies in total, including CASI Pharmaceuticals Inc (CASI) .
Insider Ownership Summary of Idg-accel China Growth Fund Iii L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CASI | CASI Pharmaceuticals Inc | 2018-03-21 | 10 percent owner |
Idg-accel China Growth Fund Iii L.p. Latest Holdings Summary
Idg-accel China Growth Fund Iii L.p. currently owns a total of 1 stock. Idg-accel China Growth Fund Iii L.p. owns 977,337 shares of CASI Pharmaceuticals Inc (CASI) as of March 21, 2018, with a value of $6 Million.
Latest Holdings of Idg-accel China Growth Fund Iii L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CASI | CASI Pharmaceuticals Inc | 2018-03-21 | 977,337 | 6.54 | 6,391,784 |
Holding Weightings of Idg-accel China Growth Fund Iii L.p.
Idg-accel China Growth Fund Iii L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Idg-accel China Growth Fund Iii L.p. has made a total of 0 transactions in CASI Pharmaceuticals Inc (CASI) over the past 5 years. The most-recent trade in CASI Pharmaceuticals Inc is the acquisition of 308,642 shares on March 21, 2018, which cost Idg-accel China Growth Fund Iii L.p. around $10 Million.
Insider Trading History of Idg-accel China Growth Fund Iii L.p.
- 1
Idg-accel China Growth Fund Iii L.p. Trading Performance
GuruFocus tracks the stock performance after each of Idg-accel China Growth Fund Iii L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Idg-accel China Growth Fund Iii L.p. is 11.75%. GuruFocus also compares Idg-accel China Growth Fund Iii L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Idg-accel China Growth Fund Iii L.p. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Idg-accel China Growth Fund Iii L.p.'s insider trading performs compared to the benchmark.
Performance of Idg-accel China Growth Fund Iii L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 34.2 | | | | | |
| Relative Return to S&P 500(%) | 34.68 | | | | | |
Idg-accel China Growth Fund Iii L.p. Ownership Network
Idg-accel China Growth Fund Iii L.p. Owned Company Details
What does CASI Pharmaceuticals Inc do?
Who are the key executives at CASI Pharmaceuticals Inc?
Idg-accel China Growth Fund Iii L.p. is the 10 percent owner of CASI Pharmaceuticals Inc. Other key executives at CASI Pharmaceuticals Inc include director & 10 percent owner & Chairman and CEO Wei-wu He , Chief Financial Officer Weihao Xu , and President Larry Zhang .
CASI Pharmaceuticals Inc (CASI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CASI Pharmaceuticals Inc (CASI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CASI Pharmaceuticals Inc (CASI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CASI Pharmaceuticals Inc (CASI)'s detailed insider trading history can be found in Insider Trading Tracker table.
CASI Pharmaceuticals Inc Insider Transactions
Idg-accel China Growth Fund Iii L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Idg-accel China Growth Fund Iii L.p.. You might contact Idg-accel China Growth Fund Iii L.p. via mailing address: Unit 5505, 55th Floor, The Center, 99 Queen's Road K3 00000.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
